DUPONT JAKOB sold 47.5% of their position (35K shares) of PYXIS ONCOLOGY, INC. on the open market
Open‑market sale worth $107.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2026ACC: 0001193125-26-294708
-35K
Net shares
Net seller
$107.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
35K acquired · 70K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+35K
Price / share
$1.60
Trade value
$56K
% of position
90.3%
6/30/2026
38.74K→73.74K
Common Stock
Direct
Shares
−35K
Price / share
$3.06
Trade value
$107.10K
% of position
47.5%
6/30/2026
73.74K→38.74K
Total
Net shares
+0.00
Net value
-$51.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | M · Option Exercise | +35K | $1.60 | $56K | 90.3% | 38.74K | 73.74K |
| Common Stock Direct | 6/30/2026 | S · Sale | −35K | $3.06 | $107.10K | 47.5% | 73.74K | 38.74K |
| Total | +0.00 | -$51.10K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
35K shares
Shares
−35K
Strike price
1.6
Held after
357.46K
Exercisable
—
6/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock35K shares | 6/30/2026 | M · Option Exercise | −35K | 1.6 | — | 357.46K |